D. Sechter

4.1k total citations
85 papers, 3.2k citations indexed

About

D. Sechter is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, D. Sechter has authored 85 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Psychiatry and Mental health, 17 papers in Pharmacology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in D. Sechter's work include Schizophrenia research and treatment (20 papers), Electroconvulsive Therapy Studies (15 papers) and Treatment of Major Depression (15 papers). D. Sechter is often cited by papers focused on Schizophrenia research and treatment (20 papers), Electroconvulsive Therapy Studies (15 papers) and Treatment of Major Depression (15 papers). D. Sechter collaborates with scholars based in France, United States and Canada. D. Sechter's co-authors include Salomón Z. Langer, E. Zarifian, Rita Raisman, Michael S. Briley, Hagop S. Akiskal, Sylvie Lancrenon, Liliane Châtenet-Duchêne, Jean‐Michel Azorin, Élie Hantouche and Pierre Vandel and has published in prestigious journals such as Science, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

D. Sechter

79 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D. Sechter 1.7k 698 661 617 402 85 3.2k
Koichi Otani 1.4k 0.8× 570 0.8× 695 1.1× 688 1.1× 507 1.3× 204 3.5k
Trevor Silverstone 1.6k 0.9× 732 1.0× 629 1.0× 634 1.0× 225 0.6× 132 3.5k
Miro Jakovljević 1.3k 0.7× 1.3k 1.8× 352 0.5× 372 0.6× 257 0.6× 188 3.8k
Raben Rosenberg 974 0.6× 407 0.6× 846 1.3× 627 1.0× 341 0.8× 83 3.1k
David B Menkes 695 0.4× 577 0.8× 487 0.7× 839 1.4× 513 1.3× 121 3.0k
Jean-Pierre Lindenmayer 2.9k 1.7× 840 1.2× 424 0.6× 544 0.9× 424 1.1× 43 4.0k
Corinne Cather 1.8k 1.1× 909 1.3× 323 0.5× 229 0.4× 527 1.3× 119 3.8k
Rif S. El‐Mallakh 2.3k 1.3× 430 0.6× 397 0.6× 629 1.0× 916 2.3× 252 3.8k
Esa Leìnonen 1.7k 1.0× 622 0.9× 1000 1.5× 661 1.1× 414 1.0× 161 3.6k
George M. Simpson 3.1k 1.8× 889 1.3× 721 1.1× 404 0.7× 369 0.9× 154 4.4k

Countries citing papers authored by D. Sechter

Since Specialization
Citations

This map shows the geographic impact of D. Sechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sechter more than expected).

Fields of papers citing papers by D. Sechter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Sechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sechter. The network helps show where D. Sechter may publish in the future.

Co-authorship network of co-authors of D. Sechter

This figure shows the co-authorship network connecting the top 25 collaborators of D. Sechter. A scholar is included among the top collaborators of D. Sechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Sechter. D. Sechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haffen, Émmanuel, et al.. (2013). Validation française de l’échelle psychométrique ASEX d’évaluation des troubles sexuels dans la dépression. L Encéphale. 40(2). 114–122. 16 indexed citations
2.
Nicolier, Magali, Gilles Chopard, Pierre Vandel, et al.. (2012). Resting motor threshold changes and clinical response to prefrontal repetitive transcranial magnetic stimulation in depressed patients. Psychiatry and Clinical Neurosciences. 66(4). 344–352. 17 indexed citations
3.
Haffen, Émmanuel, Gilles Chopard, Éloi Magnin, et al.. (2011). A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease. Brain stimulation. 5(3). 264–266. 45 indexed citations
4.
Sechter, D., et al.. (2008). L’alliance thérapeutique au début d’une prise en charge pour dépression par le généraliste. L Encéphale. 34(2). 205–210. 9 indexed citations
5.
Blin, Patrick, et al.. (2005). Utilisation des neuroleptiques chez les patients ambulatoires souffrant de schizophrénie. Revue d Épidémiologie et de Santé Publique. 53(6). 601–613. 4 indexed citations
6.
Akiskal, Hagop S., Kareen K. Akiskal, J.‐F. Allilaire, et al.. (2004). Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study. Journal of Affective Disorders. 85(1-2). 29–36. 78 indexed citations
7.
Sechter, D., et al.. (2004). A comparative study of milnacipran and paroxetine in outpatients with major depression. Journal of Affective Disorders. 83(2-3). 233–236. 38 indexed citations
8.
Akiskal, Hagop S., D. Sechter, Marc Louis Bourgeois, et al.. (2002). Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). Journal of Affective Disorders. 73(1-2). 65–74. 125 indexed citations
9.
Allilaire, J.‐F., Élie Hantouche, D. Sechter, et al.. (2001). [Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].. PubMed. 27(2). 149–58. 67 indexed citations
10.
Akiskal, Hagop S., Élie Hantouche, M Bourgeois, et al.. (2001). Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. Journal of Affective Disorders. 67(1-3). 89–96. 92 indexed citations
11.
Vandel, Pierre, et al.. (2000). Effets indésirables extrapyramidaux des neuroleptiques et antidépresseurs - recherche de facteurs de risque : rôle du polymorphisme génétique du CYP2D6. 26(1). 62–67. 1 indexed citations
12.
Vandel, Pierre, et al.. (1999). [Clinical tolerance of a new antidepressant -- milnacipran].. PubMed. 25(3). 252–8. 8 indexed citations
13.
Sechter, D., et al.. (1999). A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. European Psychiatry. 14(1). 41–48. 45 indexed citations
14.
Vandel, Pierre, Émmanuel Haffen, S Vandel, et al.. (1999). Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes. European Journal of Clinical Pharmacology. 55(9). 659–665. 38 indexed citations
15.
Bonin, B, Pierre Vandel, D. Sechter, & P Bízouard. (1997). Paroxetine and Galactorrhea. Pharmacopsychiatry. 30(4). 133–134. 17 indexed citations
16.
Vandel, Pierre, B Bonin, S Vandel, D. Sechter, & P Bízouard. (1996). CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effects. Medical Hypotheses. 47(6). 439–442. 6 indexed citations
17.
Sechter, D., et al.. (1994). [Action and tolerance of dothiepin hydrochloride (Prothiaden) in depressive states during the evolution of psychotic disorders].. PubMed. 20(4). 445–50. 1 indexed citations
18.
Bertschy, Gilles, S Vandel, B Bonin, et al.. (1992). METABOLIC INTERACTION BETWEEN TRICYCLIC ANTIDEPRESSANT AND FLUVOXAMINE AND FLUOXETINE, A PHARMACOGENETIC APPROACH. Clinical Neuropharmacology. 15. 78A–79A. 3 indexed citations
19.
Bouquet, S., S Vandel, Gilles Bertschy, et al.. (1992). PHARMACOKINETICS OF FLUOXETINE AND FLUVOXAMINE IN DEPRESSED PATIENTS: PERSONAL RESULTS. Clinical Neuropharmacology. 15. 82A–83A. 5 indexed citations
20.
Sechter, D., et al.. (1979). [Clomipramine : its use in depression and diseases other than depression].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 137(3-4). 236–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Otani Breakdown of academic impact, for papers by Trevor Silverstone Breakdown of academic impact, for papers by Miro Jakovljević Breakdown of academic impact, for papers by Raben Rosenberg Breakdown of academic impact, for papers by David B Menkes Breakdown of academic impact, for papers by Jean-Pierre Lindenmayer Breakdown of academic impact, for papers by Corinne Cather Breakdown of academic impact, for papers by Rif S. El‐Mallakh Breakdown of academic impact, for papers by Esa Leìnonen Breakdown of academic impact, for papers by George M. Simpson
Rankless by CCL
2026